Sotera Selling General Administrative vs Depreciation And Amortization Analysis
SHC Stock | USD 12.82 0.41 3.30% |
Sotera Health financial indicator trend analysis is much more than just breaking down Sotera Health prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sotera Health is a good investment. Please check the relationship between Sotera Health Selling General Administrative and its Depreciation And Amortization accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sotera Health Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Selling General Administrative vs Depreciation And Amortization
Selling General Administrative vs Depreciation And Amortization Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sotera Health Selling General Administrative account and Depreciation And Amortization. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Sotera Health's Selling General Administrative and Depreciation And Amortization is 0.55. Overlapping area represents the amount of variation of Selling General Administrative that can explain the historical movement of Depreciation And Amortization in the same time period over historical financial statements of Sotera Health Co, assuming nothing else is changed. The correlation between historical values of Sotera Health's Selling General Administrative and Depreciation And Amortization is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling General Administrative of Sotera Health Co are associated (or correlated) with its Depreciation And Amortization. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation And Amortization has no effect on the direction of Selling General Administrative i.e., Sotera Health's Selling General Administrative and Depreciation And Amortization go up and down completely randomly.
Correlation Coefficient | 0.55 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Selling General Administrative
Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.Most indicators from Sotera Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sotera Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sotera Health Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. At present, Sotera Health's Enterprise Value Multiple is projected to decrease significantly based on the last few years of reporting.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 518.7M | 557.0M | 577.2M | 522.3M | Total Revenue | 931.5M | 1.0B | 1.0B | 976.6M |
Sotera Health fundamental ratios Correlations
Click cells to compare fundamentals
Sotera Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sotera Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Other Current Liab | 60.7M | 48.0M | 49.8M | 481.2M | 107.8M | 113.4M | |
Total Current Liabilities | 124.0M | 140.6M | 161.2M | 791.6M | 230.7M | 221.2M | |
Other Liab | 253.4M | 253.8M | 298.7M | 150.3M | 172.8M | 198.8M | |
Net Tangible Assets | (2.4B) | (1.3B) | (1.1B) | (1.2B) | (1.1B) | (1.2B) | |
Retained Earnings | (550.5M) | (589.1M) | (472.2M) | (705.8M) | (654.4M) | (621.7M) | |
Accounts Payable | 42.0M | 52.4M | 72.9M | 74.1M | 71.0M | 49.6M | |
Other Assets | 18.8M | 77.1M | 33.6M | 82.9M | 95.3M | 100.1M | |
Net Receivables | 111.6M | 131.0M | 134.0M | 155.7M | 175.5M | 118.6M | |
Other Current Assets | 10.4M | 47.5M | 50.7M | 56.9M | 28.1M | 28.3M | |
Other Stockholder Equity | (94.4M) | 1.1B | 1.1B | 1.2B | 1.2B | 736.6M | |
Total Current Assets | 252.4M | 315.0M | 346.0M | 645.0M | 557.2M | 344.3M | |
Property Plant Equipment | 577.6M | 651.9M | 690.7M | 796.8M | 916.3M | 546.2M | |
Total Assets | 2.6B | 2.8B | 2.8B | 3.1B | 3.1B | 3.1B | |
Short Long Term Debt Total | 2.8B | 1.8B | 1.7B | 2.0B | 2.3B | 1.7B | |
Total Stockholder Equity | (642.6M) | 454.6M | 586.1M | 350.2M | 443.7M | 226.7M | |
Property Plant And Equipment Net | 582.0M | 655.8M | 690.7M | 801.0M | 971.0M | 785.9M | |
Current Deferred Revenue | 3.6M | 6.1M | 8.7M | 12.1M | 13.5M | 8.9M | |
Net Debt | 2.8B | 1.7B | 1.6B | 1.6B | 2.0B | 1.6B | |
Cash | 62.9M | 102.5M | 106.9M | 396.3M | 296.4M | 194.6M | |
Non Current Assets Total | 2.3B | 2.4B | 2.4B | 2.5B | 2.6B | 2.7B | |
Non Currrent Assets Other | 12.2M | 9.3M | 18.3M | 39.8M | 60.2M | 63.2M | |
Long Term Debt | 2.8B | 1.8B | 1.7B | 1.7B | 2.2B | 1.7B | |
Cash And Short Term Investments | 62.9M | 102.5M | 106.9M | 396.3M | 301.7M | 195.5M | |
Good Will | 1.0B | 1.1B | 1.1B | 1.1B | 1.1B | 1.2B | |
Common Stock Shares Outstanding | 284.4M | 283.2M | 279.4M | 280.1M | 283.2M | 303.7M | |
Liabilities And Stockholders Equity | 2.6B | 2.8B | 2.8B | 3.1B | 3.1B | 3.1B | |
Non Current Liabilities Total | 3.1B | 2.2B | 2.0B | 2.0B | 2.5B | 1.9B | |
Capital Lease Obligations | 31.2M | 84.4M | 84.3M | 87.8M | 98.6M | 76.9M | |
Inventory | 37.4M | 34.1M | 54.3M | 37.1M | 52.0M | 46.3M | |
Total Liab | 3.2B | 2.3B | 2.2B | 2.8B | 2.7B | 2.1B | |
Net Invested Capital | 2.2B | 2.3B | 1.7B | 2.3B | 2.7B | 2.5B | |
Property Plant And Equipment Gross | 582.0M | 655.8M | 690.7M | 801.0M | 1.5B | 878.5M | |
Accumulated Other Comprehensive Income | (94.4M) | (93.8M) | (83.6M) | (106.7M) | (92.7M) | (97.3M) | |
Non Current Liabilities Other | 20.6M | 17.5M | 164.2M | 12.8M | 8.9M | 8.4M | |
Net Working Capital | 128.4M | 174.4M | 184.8M | (146.6M) | 326.6M | 342.9M | |
Short Term Debt | 17.6M | 21.1M | 20.9M | 215.7M | 34.2M | 59.8M | |
Intangible Assets | 696.0M | 643.4M | 598.8M | 491.3M | 416.3M | 481.6M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sotera Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sotera Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sotera Health Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sotera Health Co Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sotera Health Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sotera Health. If investors know Sotera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sotera Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.62) | Earnings Share 0.25 | Revenue Per Share 3.969 | Quarterly Revenue Growth 0.085 | Return On Assets 0.0768 |
The market value of Sotera Health is measured differently than its book value, which is the value of Sotera that is recorded on the company's balance sheet. Investors also form their own opinion of Sotera Health's value that differs from its market value or its book value, called intrinsic value, which is Sotera Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sotera Health's market value can be influenced by many factors that don't directly affect Sotera Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sotera Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sotera Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sotera Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.